{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T08:12:50Z","timestamp":1788250370985,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5R01-HL-136647"],"award-info":[{"award-number":["5R01-HL-136647"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["CAVERL20Y5"],"award-info":[{"award-number":["CAVERL20Y5"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jcf.2024.07.005","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T17:07:01Z","timestamp":1723655221000},"page":"943-946","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Impact of day-to-day variation in FEV1 on measures of change: A conceptual description"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1221-3746","authenticated-orcid":false,"given":"Amalia S.","family":"Magaret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3238-3769","authenticated-orcid":false,"given":"Ellen","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay J.","family":"Caverly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5106-0607","authenticated-orcid":false,"given":"Elizabeth A.","family":"Cromwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8381-8550","authenticated-orcid":false,"given":"Alex","family":"Paynter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8105-614X","authenticated-orcid":false,"given":"Margaret","family":"Rosenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6820-6211","authenticated-orcid":false,"given":"Christina S.","family":"Thornton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher H.","family":"Goss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jcf.2024.07.005_bib0001","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1164\/rccm.201404-0703OC","article-title":"Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis","volume":"190","author":"Rowe","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.jcf.2024.07.005_bib0002","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jcf.2017.01.002","article-title":"Use of FEV1 in cystic fibrosis epidemiologic studies and clinical trials: a statistical perspective for the clinical researcher","volume":"16","author":"Szczesniak","year":"2017","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.07.005_bib0003","first-page":"55","article-title":"A systematic review of studies examining the rate of lung function decline in patients with cystic fibrosis","volume":"20","author":"Harun","year":"2016","journal-title":"Paediatr Respir Rev"},{"issue":"5","key":"10.1016\/j.jcf.2024.07.005_bib0004","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jcf.2012.03.009","article-title":"Risk factors for rate of decline in FEV1 in adults with cystic fibrosis","volume":"11","author":"Konstan","year":"2012","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.jcf.2024.07.005_bib0005","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jcf.2023.05.011","article-title":"Quantifying variation in home spirometry in people with cystic fibrosis during baseline health, and associations with clinical outcomes","volume":"23","author":"Thornton","year":"2024","journal-title":"J Cyst Fibr"},{"key":"10.1016\/j.jcf.2024.07.005_bib0006","unstructured":"Nichols D.P., Rowe S.M. Spirometry data from ongoing PROMISE study (NCT04038047). 2023."},{"issue":"1","key":"10.1016\/j.jcf.2024.07.005_bib0007","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jcf.2021.08.013","article-title":"A comparison of clinic and home spirometry as longtudinal outcomes in cystic fibrosis","volume":"21","author":"Paynter","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"13","key":"10.1016\/j.jcf.2024.07.005_bib0008","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.290.13.1749","article-title":"Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial","volume":"290","author":"Saiman","year":"2003","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jcf.2024.07.005_bib0009","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1038\/s41467-024-49150-y","article-title":"Microbial community organization designates distinct pulmonary exacerbation types and predicts treatment outcome in cystic fibrosis","volume":"15","author":"Widder","year":"2024","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.jcf.2024.07.005_bib0010","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1513\/AnnalsATS.202209-829OC","article-title":"Lung function decline in cystic fibrosis impact of data availability and modeling strategies on clinical interpretations","volume":"20","author":"Szczesniak","year":"2023","journal-title":"Ann Am Thorac Soc"},{"issue":"4","key":"10.1016\/j.jcf.2024.07.005_bib0011","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00204-2022","article-title":"Dutch cystic fibrosis registry steering g. long-term effectiveness of dual CFTR modulator treatment of cystic fibrosis","volume":"8","author":"Muilwijk","year":"2022","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jcf.2024.07.005_bib0012","series-title":"Applied linear statistical models: regression, analysis of variance, and experimental designs","first-page":"1181","author":"Neter","year":"1990"},{"issue":"1","key":"10.1016\/j.jcf.2024.07.005_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting Linear Mixed-Effects Models Using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J Stat Softw"},{"issue":"1","key":"10.1016\/j.jcf.2024.07.005_bib0014","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/ije\/dyh299","article-title":"Regression to the mean: what it is and how to deal with it","volume":"34","author":"Barnett","year":"2005","journal-title":"Int J Epidemiol"},{"issue":"2","key":"10.1016\/j.jcf.2024.07.005_bib0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/096228029700600202","article-title":"Regression towards the mean, historically considered","volume":"6","author":"Stigler","year":"1997","journal-title":"Stat Methods Med Res"},{"issue":"10","key":"10.1016\/j.jcf.2024.07.005_bib0016","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/thoraxjnl-2020-214817","article-title":"Paediatric reproducibility limits for the forced expiratory volume in 1 s","volume":"75","author":"Stanojevic","year":"2020","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2024.07.005_bib0017","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.jcf.2024.07.005_bib0018","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor\u2013Tezacaftor\u2013Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jcf.2024.07.005_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2024.101378","article-title":"Baseline-dependent improvement in cystic fibrosis studies, plausibility of bias","author":"Graham","year":"2024","journal-title":"Contemporary Clinical Trials Communications"},{"issue":"7","key":"10.1016\/j.jcf.2024.07.005_bib0020","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/sim.1352","article-title":"Analysis of associations with change in a multivariate outcome variable when baseline is subject to measurement error","volume":"22","author":"Chambless","year":"2003","journal-title":"Stat Med"},{"issue":"22","key":"10.1016\/j.jcf.2024.07.005_bib0021","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1002\/(SICI)1097-0258(19981130)17:22<2597::AID-SIM940>3.0.CO;2-G","article-title":"The effects of measurement error in response variables and tests of association of explanatory variables in change models","volume":"17","author":"Yanez","year":"1998","journal-title":"Stat Med"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199324007902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199324007902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:12:58Z","timestamp":1788246778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199324007902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1569199324007902"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2024.07.005","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of day-to-day variation in FEV1 on measures of change: A conceptual description","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2024.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}